Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises funds managed by Triton in connection with acquisition
Mandate

Vinge advises funds managed by Triton in connection with acquisition

April 30, 2018 Banking and Finance

Vinge has advised funds managed by Triton in connection with the acquisition of the privately owned company Mark & Energibyggarna i Göteborg AB, a supplementary acquisition to its portfolio company Akeab.

Mark & Energibyggarna is a successful supplier of services within facility construction in the Gothenburg area. Mark & Energibyggarna is connected to KEWAB and Akeab as a new sister company in an infrastructure group, focused on facility and construction work, owned by Triton and the management of the companies in question.

Vinge’s team consisted of partner Christina Kokko together with, among others, associates Oscar Rydén, Johanna Wiberg and Michaela Cronemyr. Partner Albert Wållgren and associates Adelwald and Sara Osman provided financing advice. Partner Marcus Glader and associates Xandra Ståhlberg and Fredrika Hjelmberg provided competition law advice.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025